Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)

v3.22.1
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]        
Revenue $ 470,623 $ 422,722 $ 989,808 $ 804,060
Cost of Revenue 65,900 73,469 158,136 133,803
Gross Profit 404,723 349,253 831,672 670,257
Operating Expenses:        
Selling expenses 135,865 109,272 324,410 270,131
Administrative expenses 115,125 128,717 243,040 221,083
Amortization and depreciation 960 451 1,774 902
Research and development 47,016 39,538 96,276 70,327
Total Operating Expenses 298,966 277,978 665,500 562,443
Interest expense, net (101) (153) (269) (1,268)
Total Other Expense (101) (153) (269) (1,268)
Income before income taxes 105,656 71,122 165,903 106,546
Provision for income taxes    
Net Income 105,656 71,122 165,903 106,546
Preferred stock dividends Series A Preferred (10,119) (10,119) (20,463) (20,465)
Net income attributable to common stockholders $ 95,537 $ 61,003 $ 145,440 $ 86,081
Net income per common share - basic (in Dollars per share) $ 0 $ 0 $ 0 $ 0
Net income per common share - diluted (in Dollars per share) $ 0 $ 0 $ 0 $ 0
Weighted Average of number of shares outstanding - basic (in Shares) 228,359,918 224,195,273 228,359,918 224,195,273
Weighted Average of number of shares outstanding - diluted (in Shares) 599,721,553 598,407,968 599,721,553 598,407,968